Author | Elefterios Hamilakis, PharmD Candidate 2020

Articles

Lumateprone Tosylate Approved for Schizophrenia

April 09, 2020

The FDA has approved lumateperone tosylate (Caplyta™, Intra-Cellular Therapies) for treatment of schizophrenia in adults.